Investors of Zoetis Inc. Notified About Lawsuit Opportunity for Securities Fraud Claims

Opportunity for Investors: Join the Zoetis Class Action

If you've purchased securities from Zoetis Inc. (NYSE: ZTS) between January 14, 2025, and May 6, 2026, you might be entitled to compensation through a class action lawsuit. The Rosen Law Firm, a prominent global investor rights law firm, is urging affected investors to take action before the lead plaintiff deadline on July 27, 2026.

The law firm emphasizes that there are no out-of-pocket costs for participating in this lawsuit, thanks to a contingency fee arrangement. This means that investors can join the class action and potentially recover their losses without any initial financial risk.

Understanding the Lawsuit

The heart of the lawsuit revolves around claims that Zoetis made misleading statements that inflated its market position and company performance during the class period. Specifically, it's alleged that while the company touted strong sales growth and a burgeoning market share in its flagship Companion Animal products, it failed to disclose critical issues affecting its products.
1. Veterinarian Prescription Growth: There were concerning safety warnings from the FDA regarding Zoetis' Librela, a dog pain treatment, which led to decreased veterinarian prescription rates.
2. Market Share Losses: Zoetis' Simparica Trio faced stiff competition from lower-priced canine parasitic treatments. This financial stress contributed to a decline in overall sales within a challenging market.
3. Dermatology Product Struggles: Zoetis’ dermatology products, Apoquel and Cytopoint, also lost substantial ground to newly launched competitors.

The lawsuit, when initiated, alleges that the dissemination of this information led to a decline in stock prices, resulting in significant losses for investors. The Rosen Law Firm advises that if you wish to be considered as a lead plaintiff in the lawsuit, action must be taken by the stated deadline.

Taking Action

To join the ongoing case and potentially reclaim your losses, investors have several options:

- Visit the Rosen Law Firm's website at rosenlegal.com.
- Call Phillip Kim, Esq. toll-free at 866-767-3653.
- Email at [email protected].

An important note is that a class has not yet been certified, meaning that investors are not represented unless they retain an attorney. You can choose to select your legal counsel or remain an absent class member.

About the Rosen Law Firm

The Rosen Law Firm has built a reputation for representing investors globally, primarily focusing on securities class actions and shareholder derivative litigation. With a proven track record, including recovering hundreds of millions for investors, the firm has been recognized in the industry for its success in similar cases. It has achieved notable settlements, including the largest securities class action settlement against a Chinese company. Laurence Rosen, one of the firm's founding partners, has been awarded accolades recognizing his contributions to plaintiffs' rights.

Investors are encouraged to act swiftly to ensure their voices are heard in this action. For ongoing updates about the case and to engage with the firm, you can also follow them on LinkedIn, Twitter, and Facebook.

Stay informed and proactive as your potential recovery could hinge on timely actions in this critical period.